Pharmacological targeting of type phosphodiesterase 4 inhibits the development of acute myeloid leukemia by impairing mitochondrial function through the Wnt/β-catenin pathway
Article in Biomedicine & Pharmacotherapy (November 2022)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Cyclic adenosine monophosphate/phosphodiesterase 4 pathway associated with immune infiltration and PD-L1 expression in lung adenocarcinoma cells
Article in Frontiers in Oncology (August 2022)
Ibudilast Attenuates Folic Acid–Induced Acute Kidney Injury by Blocking Pyroptosis Through TLR4-Mediated NF-κB and MAPK Signaling Pathways
Article in Frontiers in Pharmacology (May 2021)